Worldwide Healthcare Trust - Healthcare industry prospects are shining brightly
Worldwide Healthcare Trust (WWH) has two co-managers, Sven Borho and Trevor Polischuk, at global healthcare specialist OrbiMed. They are very optimistic about the fundamentals for the healthcare sector. The managers are encouraged by high levels of industry innovation, increased clarity around US drug pricing, which removes a long-term overhang, and the acceleration in M&A, which historically has been an important driver for the performance of healthcare stocks. WWH’s results have already benefited from the recent acquisitions of three of its biotech holdings at meaningful premiums to their pre-bid share prices, as pharma companies seek to bolster their revenues and pipelines ahead of an upcoming major patent cliff. The managers are particularly bullish on the prospects for emerging (smaller-cap) biotech stocks as these have experienced the worst and longest period of underperformance in their history. WWH has recently had a 10:1 share split to make the company more accessible for smaller investors.Worldwide Healthcare Trust is an investment trust. Co. invest in the global healthcare sector particularly in pharmaceutical and biotechnology companies and related securities in the healthcare sector. In addition, Co. invests in medical device technologies, life science tools and healthcare services. A maximum of 20% of the portfolio, at the time of acquisition, may be invested in companies in each of the following sectors: healthcare equipment and supplies; healthcare technology; and healthcare providers and services. Co.'s investment portfolio at Mar 31 2017, principally comprised listed equity investments, OTC swaps and unquoted debt investments and totalled £1,192,881,000.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.